Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450626 · ClinicalTrials.gov registry record · NA
Music Therapy at TMH Infusion Center
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06450626: Completed NA study, sponsored by Brown University.
NCT06450626 is a NA study that has completed, run by Brown University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06450626, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the effects of a listening music intervention on the symptom burden carried by patients who are receiving infusions at the Lifespan Cancer Institute of Miriam Hospital in Providence, Rhode Island. The main questions it aims to answer are: * Will a music therapy intervention help reduce physical and mental symptom burden? * Will a music therapy intervention be beneficial on physiological parameters during the infusion sessions, such as heart rate, respiratory rate, and blood rate? Participants will undergo the following main tasks: * Prior to the infusion, participants will be given a pre-assessment survey reflecting on their previous experiences with infusions. * During the infusion, participants will listen to a self-selected playlist either on their own device or on an iPad provided by the clinic, and vitals will be monitored. * After the session, participants will be given a post-assessment survey to evaluate outcomes of the intervention. * Participants will also be asked a set of qualitative questions about their overall experience with the music therapy session.
Primary Outcome
The Edmonton Symptom Assessment Scale (ESAS) is now commonly used for symptom screening and longitudinal monitoring in patients seen by palliative care, oncology, nephrology, and other disciplines in both inpatient and outpatient settings. The ESAS is also a valid and reliable tool to assist in the assessment of nine common symptoms experienced by cancer patients. Possibles scores for each symptom range from 0 (no symptom feeling) to 10 (worst symptom feeling)
Interventions
- OTHER Listening Music Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-06-19 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT06450626 record still lists
NCT06450626 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Listening Music Intervention is the first listed.
NCT06450626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06450626 about?
NCT06450626 is a clinical study titled "Music Therapy at TMH Infusion Center". The goal of this clinical trial is to test the effects of a listening music intervention on the symptom burden carried by patients who are receiving infusions at the Lifespan Cancer Institute of Miriam Hospital in Providence, Rhode Island. The main questions it aims to answer are: * Will a music th...
What is the current status of trial NCT06450626?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2024-06-19. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06450626?
The interventions under investigation include: Listening Music Intervention (OTHER).
Who is sponsoring clinical trial NCT06450626?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06450626's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI